Vasantha H S Kumar1,2, Rita Dadiz3, Jamie Koumoundouros4, Stephanie Guilford4, Satyan Lakshminrusimha5. 1. Department of Pediatrics, University at Buffalo, Buffalo, NY, USA. vkumar3@buffalo.edu. 2. Division of Neonatology, Department of Pediatrics, John R Oishei Children's Hospital, University at Buffalo, 1001 5th Floor Main Street, Buffalo, NY, 14203, USA. vkumar3@buffalo.edu. 3. University of Rochester Medical Center, Rochester, NY, USA. 4. Department of Pediatrics, University at Buffalo, Buffalo, NY, USA. 5. Department of Pediatrics, University of California Davis Children's Hospital, Sacramento, CA, USA.
Abstract
BACKGROUND: Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, cardiac dysfunction and pulmonary hypertension. Inhaled nitric oxide (iNO) and milrinone are commonly used pulmonary vasodilators in CDH. We studied the hemodynamic effects of iNO and milrinone in infants with CDH. METHODS: A retrospective chart review was performed of all CDH infants admitted to two regional perinatal centers and infants classified into three groups: No-iNO group; iNO-responders and iNO-nonresponders. Oxygenation and hemodynamic effects of iNO and milrinone were assessed by blood gases and echocardiography. RESULTS: Fifty-four percent (39/72) of infants with CDH received iNO and 31% of these infants (12/39) had complete oxygenation response to iNO. Oxygenation response to iNO was not associated with a decrease in right ventricular pressures (RVP) or ECMO use. Four infants (33%) in the iNO-responder group and eight infants (30%) in the iNO-nonresponder group received milrinone. Milrinone lowered RVP and improved ejection fraction (EF). Response to iNO was associated with improved oxygenation to milrinone and increased survival following ECMO (67 vs. 20% among nonresponders). CONCLUSIONS: Response to inhaled nitric oxide in combination with milrinone may be associated with improved oxygenation and better survival after ECMO in infants with CDH.
BACKGROUND:Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, cardiac dysfunction and pulmonary hypertension. Inhaled nitric oxide (iNO) and milrinone are commonly used pulmonary vasodilators in CDH. We studied the hemodynamic effects of iNO and milrinone in infants with CDH. METHODS: A retrospective chart review was performed of all CDH infants admitted to two regional perinatal centers and infants classified into three groups: No-iNO group; iNO-responders and iNO-nonresponders. Oxygenation and hemodynamic effects of iNO and milrinone were assessed by blood gases and echocardiography. RESULTS: Fifty-four percent (39/72) of infants with CDH received iNO and 31% of these infants (12/39) had complete oxygenation response to iNO. Oxygenation response to iNO was not associated with a decrease in right ventricular pressures (RVP) or ECMO use. Four infants (33%) in the iNO-responder group and eight infants (30%) in the iNO-nonresponder group received milrinone. Milrinone lowered RVP and improved ejection fraction (EF). Response to iNO was associated with improved oxygenation to milrinone and increased survival following ECMO (67 vs. 20% among nonresponders). CONCLUSIONS: Response to inhaled nitric oxide in combination with milrinone may be associated with improved oxygenation and better survival after ECMO in infants with CDH.
Authors: Vasanth H Kumar; Daniel D Swartz; Nasir Rashid; Satyan Lakshminrusimha; Changxing Ma; Rita M Ryan; Frederick C Morin Journal: J Appl Physiol (1985) Date: 2010-07-08
Authors: Adam T James; John D Corcoran; Patrick J McNamara; Orla Franklin; Afif F El-Khuffash Journal: Cardiol Young Date: 2015-01-20 Impact factor: 1.093
Authors: Luke R Putnam; Matthew T Harting; Kuojen Tsao; Francesco Morini; Bradley A Yoder; Matías Luco; Pamela A Lally; Kevin P Lally Journal: Pediatrics Date: 2016-11 Impact factor: 7.124
Authors: Satyan Lakshminrusimha; Nicolas F M Porta; Kathryn N Farrow; Bernadette Chen; Sylvia F Gugino; Vasanth H Kumar; James A Russell; Robin H Steinhorn Journal: Pediatr Crit Care Med Date: 2009-01 Impact factor: 3.624
Authors: Ruth B Seabrook; Theresa R Grover; Natalie Rintoul; Mark Weems; Sarah Keene; Beverly Brozanski; Robert DiGeronimo; Beth Haberman; Holly Hedrick; Jason Gien; Noorjahan Ali; Rachel Chapman; John Daniel; H Allen Harrison; Yvette Johnson; Nicolas F M Porta; Michael Uhing; Isabella Zaniletti; Karna Murthy Journal: J Perinatol Date: 2021-03-01 Impact factor: 2.521